Language
Classification of HER2 Receptor Status in Breast Cancer Tissues by MALDI Imaging Mass Spectrometry
| Type: | Application |
Poster |
Clinical Proteomics, Expression Proteomics |
| Number: | Technology |
DGMS 2010 |
MALDI-TOF |
| Year | Products |
2010 |
ultraflex III |
| Author | |
Sandra Rauser (1); Claudio Marquardt (1); Benjamin Balluff (1,2); Christian Albers (3); Eckhard Belau (3); Ralf Hartmer (3); Detlev Suckau (3); Katja Specht (4); Matthias P Ebert (2); Manfred Schmitt (5); Michaela Aubele (1); Heinz Höfler (1); Ulrike Anders (3); Axel Walch (1) (1) Institute of Pathology, Helmholtz Zentrum München, Neuherberg; (2) Department of Medicine II, Klinikum rechts der Isar, Munich; (3) Bruker Daltonik GmbH, Bremen; (4) Institute of Pathology, TUM, Munich; (5) Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Munich |
|
| Reference | |
DGMS |
|
Abstract |
|
A new 8.4 kDa biomarker candidate for HER2-positive breast cancer, the cytosolic protein CRIP1 was established by High Definition MALDI Imaging and Top-Down protein ID using ETD/PTR on an ion trap. |
|
Related Products |
|
Download |
|
